Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

2,962 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

NCT00163436

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed La Malbaie, Quebec, Canada
  • Altana Pharma/Nycomed London, Canada
  • Altana Pharma/Nycomed London,ON, Canada
  • Altana Pharma/Nycomed Mississauga, Canada
View all 66 locations
View Trial Details
Completed

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

NCT00163358

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Adelaide South Australia, Australia
  • Altana Pharma/Nycomed Auchenflower, Australia
  • Altana Pharma/Nycomed Bracken Ridge, Australia
  • Altana Pharma/Nycomed Burwood, Australia
View all 111 locations
View Trial Details
Completed

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

NCT01537133

Conditions
Asthma, Atopy, Bronchial Diseases, +7 more
Locations
  • University of California, San Francisco, Adult San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma

NCT01248975

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Pleven, Bulgaria
  • GSK Investigational Site Rousse, Bulgaria
  • GSK Investigational Site Varna, Bulgaria
  • GSK Investigational Site Bialystok, Poland
View all 19 locations
View Trial Details

Related conditions